WARREN, N.J. (AP) _ Aquestive Therapeutics Inc. (AQST) on Tuesday reported a loss of $18.4 million in its third quarter.
On a per-share basis, the Warren, New Jersey-based company said it had a loss of 74 cents. Losses, adjusted to extinguish debt, were 54 cents per share.
The specialty pharmaceutical company posted revenue of $12.4 million in the period.
Aquestive Therapeutics expects full-year revenue in the range of $45 million to $47 million.
In the final minutes of trading on Tuesday, the company's shares hit $4.23. A year ago, they were trading at $17.75.